Dr. Norma Biln, Norma Biln, PhD, MBA, BSc, NACD.DC, one of the founders of Augurex, explains how new biomarkers, patient questionnaires, and tools like SPINEstat aim to shorten the long diagnostic delay in spondyloarthritis by improving early detection and referral accuracy, especially in primary care settings.
